Randomized, Double-Blind, Placebo-Controlled Trial of Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Idiopathic Pneumonia Syndrome after Allogeneic Stem Cell Transplantation: Blood and Marrow Transplant Clinical Trials Network Protocol
Titel:
Randomized, Double-Blind, Placebo-Controlled Trial of Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Idiopathic Pneumonia Syndrome after Allogeneic Stem Cell Transplantation: Blood and Marrow Transplant Clinical Trials Network Protocol
Auteur:
Yanik, Gregory A. Horowitz, Mary M. Weisdorf, Daniel J. Logan, Brent R. Ho, Vincent T. Soiffer, Robert J. Carter, Shelly L. Wu, Juan Wingard, John R. Difronzo, Nancy L. Ferrara, James L. Giralt, Sergio Madtes, David K. Drexler, Rebecca White, Eric S. Cooke, Kenneth R.